Key result
Subjects in the highest tertile of plasma betatrophin had higher odds of having Type 2 Diabetes, although levels did not correlate with blood glucose or insulin resistance in diabetic subjects.
Cross-Sectional (n=1,603)
Plasma betatrophin levels are significantly elevated in patients with Type 2 Diabetes but do not correlate with fasting blood glucose or insulin resistance in these individuals, raising questions about its functional role in the disease.
Answers are grounded in this paper and cite their sources.
Highest betatrophin levels associate with T2D but not glycemic parameters; hypothesis-generating for its role, requiring longitudinal validation.
Betatrophin/ANGPTL8 is a newly identified hormone produced in liver and adipose tissue that has been shown to be induced as a result of insulin resistance and regulates lipid metabolism. Little is known about betatrophin level in humans and its association with T2D and metabolic risk factors. Plasma level of betatrophin was measured by ELISA in 1603 subjects: 1047 non-diabetic and 556 T2D subjects and its associations with metabolic risk factors in both non-diabetic and T2D were also studied. Our data show a significant difference in betatrophin levels between non-diabetic (731.3 (59.5-10625.0) pg/ml) and T2D (1710.5 (197.4-12361.1) p < 0.001. Betatrophin was positively correlated with age, BMI, waist/hip ratio, FBG, HbA1C, HOMA-IR and TG in the non-diabetic subjects. However, no association was observed with BMI, FBG, HbA1C or HOMA-IR in T2D subjects. TC and LDL showed negative association with betatrophin in T2D subjects. Multivariate analysis showed that subjects in the highest tertile of betatrophin had higher odds of having T2D (odd ratio [OR] = 6.15, 95% confidence interval [CI] = (3.15 - 12.01). Our data show strong positive associations between betatrophin and FBG and insulin resistance in non-diabetic subjects. However, correlations with FBG and insulin resistance were diminished in T2D subjects.
No takes yet. Share an insight, caveat, or question.
Abu‐Farha et al. (2015) conducted a cross-sectional in Type 2 Diabetes (n=1,603). Plasma betatrophin/ANGPTL8 level vs. Lowest tertile of betatrophin was evaluated on Odds of having Type 2 Diabetes (highest vs lowest tertile of betatrophin) (OR 6.15, 95% CI 3.15-12.01, p=<0.0001). Subjects in the highest tertile of plasma betatrophin had higher odds of having Type 2 Diabetes, although levels did not correlate with blood glucose or insulin resistance in diabetic subjects.
Synapse has enriched 10 related papers. Consider them for comparative context: